TROVAX-VET

Welcome to the Brand page for “TROVAX-VET”, which is offered here for Pharmaceutical and veterinary preparations for the treatment of cancer, auto-immune diseases, diseases of the nervous system, inflammatory diseases, vascular disorders and disorders arising from improper vascularisation; gene therapy and prophylaxis products for the veterinary treatment of cancer, vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, retroviral vector and retroviral vector manufacturing preparations; vaccines, gene therapy, prophylaxis vector and vector manufacturing preparations for the treatment of cancer in animals and humans;trovax veterinary;instruments and apparatus for the administration of vaccines, syringes and injectors; gene therapy and prophylaxis products, syringes and injectors; surgical and medical apparatus and instruments for gene therapy and prophylaxis, pre-filled syringes, vials and injectors for medical purposes for animals and humans;scientific and medical research and development for new products for animals and humans; genetic engineering services, providing scientific researches for others in the fields of genetic engineering; biotechnology services, providing research in the development of therapeutic and prophylactic products and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “TROVAX-VET” is believed to be currently owned by “Oxford BioMedica plc”.